Researchers Cast Doubt on CRISPR-Like System in Giant Viruses

Virologists challenge the hypothesis that mimiviruses possess a nucleic acid defense mechanism.

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Mimivirus particlePLOS PATHOGENS, E. GHIGO ET ALThe CRISPR/Cas defense system found in many bacteria, with its simple yet elegant method for editing a host genome, has become the biological technique of the moment, spurring a flood of recent discoveries. In March, Didier Raoult of the Aix-Marseille University in France and colleagues published a paper suggesting that a type of giant virus known as mimivirus possesses a virophage resistance mechanism—called mimivirus virophage resistance element, or MIMIVIRE—that resembles the CRISPR system. (See “Giant Virus Has CRISPR-like Immune Defense,” The Scientist, March 2, 2016.) In a perspective published last month (June 13) in Virologica Sinica, Jean-Michel Claverie and Chantal Abergel of France’s CNRS challenge this view.

“MIMIVIRE is not analogous to the CRISPR-Cas system, does not function via a nucleic acid recognition system, and is unlikely to possess all the attributes of a bona fide adaptive immune system,” Claverie and Abergel wrote in their paper. (Claverie and Raoult have worked together in the past; both told The Scientist they now have a contentious relationship.)

Claverie and Abergel go on to question whether the mimivirus virophage resistance mechanism is based on nucleic acids at all. They instead propose that proteins may be interfering with replication of virophage in the resistant mimivirus.

Giant viruses are named for their large size and massive genomes. They inhabit amoebas, and can themselves be infected by virophages. Raoult and colleagues discovered the Mimiviridae genus of mimiviruses in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Tanya Lewis

    This person does not yet have a bio.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Discover a serum-free way to produce dendritic cells and macrophages for cell therapy applications.

Optimizing In Vitro Production of Monocyte-Derived Dendritic Cells and Macrophages

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with Lipid Nanoparticles

Thermo Fisher Logo